90 related articles for article (PubMed ID: 3545451)
1. Penetration and binding of radiolabeled anti-carcinoembryonic antigen monoclonal antibodies and their antigen binding fragments in human colon multicellular tumor spheroids.
Sutherland R; Buchegger F; Schreyer M; Vacca A; Mach JP
Cancer Res; 1987 Mar; 47(6):1627-33. PubMed ID: 3545451
[TBL] [Abstract][Full Text] [Related]
2. Homogeneous penetration but heterogeneous binding of antibodies to carcinoembryonic antigen in human colon carcinoma HT-29 spheroids.
Carlsson J; Daniel-Szolgay E; Frykholm G; Glimelius B; Hedin A; Larsson B
Cancer Immunol Immunother; 1989; 30(5):269-76. PubMed ID: 2624920
[TBL] [Abstract][Full Text] [Related]
3. Differences in biodistribution of the anti-(carcinoembryonic antigen) murine monoclonal antibody CE-25, its F(ab')2 fragment and its intact mainly human chimeric form CE 4-8-13. Dependence on tumour size and amount of antibody injected.
Westera G; Rülicke T; Smith A; Duewell S
Cancer Immunol Immunother; 1994 Dec; 39(6):375-82. PubMed ID: 8001025
[TBL] [Abstract][Full Text] [Related]
4. Autoradiographic analysis of radiolabeled anti-carcinoembryonic antigen monoclonal antibody CEA102 in colorectal cancer using computed radiography.
Satoh T; Watanabe T; Tadokoro M; Sakamoto J; Murayama H; Itoh K; Sakuma S; Takagi H
Jpn J Cancer Res; 1992 Apr; 83(4):379-86. PubMed ID: 1506272
[TBL] [Abstract][Full Text] [Related]
5. Relative positions of some epitopes on carcinoembryonic antigen.
Larsson A; Ghosh R; Hammarström S
Cancer Immunol Immunother; 1989; 30(2):92-6. PubMed ID: 2480845
[TBL] [Abstract][Full Text] [Related]
6. Reactivity of a human monoclonal antibody against carcinomas and other lesions of the colon.
Formenti SC; Mitchell MS; Taylor CR; Lipkin M; Jernstrom PH; Kan-Mitchell J
Cancer Immunol Immunother; 1989; 28(4):296-300. PubMed ID: 2467741
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic studies of radiolabelled rat monoclonal antibodies recognising syngeneic sarcoma antigens. II. Effect of host age and immune status.
Eccles SA; Purvies HP; Styles JM; Hobbs SM; Dean CJ
Cancer Immunol Immunother; 1989; 30(1):13-20. PubMed ID: 2598171
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of human carcinoembryonic-antigen (CEA)-transduced and non-transduced murine tumors as potential targets for anti-CEA therapies.
Hand PH; Robbins PF; Salgaller ML; Poole DJ; Schlom J
Cancer Immunol Immunother; 1993; 36(2):65-75. PubMed ID: 8425211
[TBL] [Abstract][Full Text] [Related]
9. Parameters involved in the enhancement of monoclonal antibody targeting in vivo with recombinant interferon.
Guadagni F; Schlom J; Pothen S; Pestka S; Greiner JW
Cancer Immunol Immunother; 1988; 26(3):222-30. PubMed ID: 3383205
[TBL] [Abstract][Full Text] [Related]
10. Selective killing of carcinoembryonic-antigen (CEA)-producing cells in vitro by the immunoconjugate cytorhodin-S and CEA-reactive cytorhodin-S antibody CA208.
Iwahashi T; Tone Y; Usui J; Watanabe H; Sugawara I; Mori S; Okazaki H
Cancer Immunol Immunother; 1989; 30(4):239-46. PubMed ID: 2598192
[TBL] [Abstract][Full Text] [Related]
11. Bispecific-Ab-based immunoassay of thyroid-stimulating hormone.
Inouye K
Cancer Immunol Immunother; 1997; 45(3-4):159-61. PubMed ID: 9435863
[TBL] [Abstract][Full Text] [Related]
12. Effects of 131I-labeled TNT-1 radioimmunotherapy on HT-29 human colon adenocarcinoma spheroids.
Chen FM; Liu CZ; Epstein AL
Cancer Immunol Immunother; 1991; 33(3):158-64. PubMed ID: 2044081
[TBL] [Abstract][Full Text] [Related]
13. Distribution of labelled anti-tenascin antibodies and fragments after injection into intact or partly resected C6-gliomas in rats.
Goetz CM; Rachinger W; Decker M; Gildehaus FJ; Stocker S; Jung G; Tatsch K; Tonn JC; Reulen HJ
Cancer Immunol Immunother; 2005 Apr; 54(4):337-44. PubMed ID: 15449040
[TBL] [Abstract][Full Text] [Related]
14. The fate of antibodies and their radiolabels bound to tumor cells in vitro: the effect of cross-linking at the cell surface and of anti-idiotype antibodies.
Ong GL; Marria V; Mattes MJ
Cancer Immunol Immunother; 1994 Nov; 39(5):325-31. PubMed ID: 7987864
[TBL] [Abstract][Full Text] [Related]
15. Relationship between tumour morphology, antigen and antibody distribution measured by fusion of digital phosphor and photographic images.
Flynn AA; Boxer GM; Begent RH; Pedley RB
Cancer Immunol Immunother; 2001 Apr; 50(2):77-81. PubMed ID: 11401028
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometric analysis of sialyl Lewis A antigen on human cancer cells by using F(ab')2μ fragments prepared from a mouse IgM monoclonal antibody.
Morimoto K; Inouye K
Cytotechnology; 1997 Sep; 24(3):219-26. PubMed ID: 22358765
[TBL] [Abstract][Full Text] [Related]
17. Quantifying Imaging Agent Binding and Dissociation in 3-D Cancer Spheroid Tissue Culture Using Paired-Agent Principles.
Li C; Rounds CC; Torres VC; He Y; Xu X; Papavasiliou G; Samkoe KS; Brankov JG; Tichauer KM
Ann Biomed Eng; 2024 Jun; 52(6):1625-1637. PubMed ID: 38409434
[TBL] [Abstract][Full Text] [Related]
18. A computational diffusion model to study antibody transport within reconstructed tumor microenvironments.
Cartaxo AL; Almeida J; Gualda EJ; Marsal M; Loza-Alvarez P; Brito C; Isidro IA
BMC Bioinformatics; 2020 Nov; 21(1):529. PubMed ID: 33203360
[TBL] [Abstract][Full Text] [Related]
19. Penetration Efficiency of Antitumor Agents in Ovarian Cancer Spheroids: The Case of Recombinant Targeted Toxin DARPin-LoPE and the Chemotherapy Drug, Doxorubicin.
Sokolova E; Kutova O; Grishina A; Pospelov A; Guryev E; Schulga A; Deyev S; Balalaeva I
Pharmaceutics; 2019 May; 11(5):. PubMed ID: 31067739
[TBL] [Abstract][Full Text] [Related]
20. Spheroids of HER2-Positive Breast Adenocarcinoma for Studying Anticancer Immunotoxins In Vitro.
Balalaeva IV; Sokolova EA; Puzhikhina AD; Brilkina AA; Deyev SM
Acta Naturae; 2017; 9(1):38-43. PubMed ID: 28461972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
